Humira

In the US, Humira (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Juvenile Idiopathic Arthritis, Psoriasis, Psoriatic Arthritis, Reiter's Syndrome and Rheumatoid Arthritis.

US matches:

• Humira


• Humira Pen


• Humira Pen Crohn's Disease Starter Package

UK matches:

• Humira 40 mg solution for injection in pre-filled syringe
• Humira 40mg solution for injection in pre-filled pen

Ingredient matches for Humira

Adalimumab

Adalimumab is reported as an ingredient of Humira in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Bulgaria


• Canada


• Chile


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Turkey


• United Kingdom


• United States

International Drug Name Search